Key result
TEE distinguishes benign lipomatous atrial septal hypertrophy from malignant intracardiac masses.
Why the study?
Can transesophageal echocardiography (TEE) accurately distinguish lipomatous atrial septal hypertrophy (LASH) from other intracardiac masses?
Can transesophageal echocardiography (TEE) accurately distinguish lipomatous atrial septal hypertrophy (LASH) from other intracardiac masses?
Answers are grounded in this paper and cite their sources.
Transesophageal echocardiography is a valuable tool for distinguishing benign lipomatous atrial septal hypertrophy from malignant intracardiac masses to guide appropriate surgical management.
Masses in and near the interatrial septum may be either benign or malignant. The most common mass near the interatrial septum is lipomatous atrial septal hypertrophy (LASH). LASH can be present in patients with intracardiac malignancies, myxomas, lipomas, or other cardiac masses. It is important to recognize the transesophageal echocardiography (TEE) characteristics of these pathologies to arrive at an accurate diagnosis with an appropriate plan for intraoperative resection. At the authors' institution, patients have been referred for surgery due to a finding of significant LASH masquerading as a left atrial myxoma. In challenging cases, TEE offers a thorough evaluation of the interatrial septum to delineate between multiple intracardiac masses.
No takes yet. Share an insight, caveat, or question.
Kleiman et al. (2018) conducted a review in Lipomatous atrial septal hypertrophy (LASH) and left atrial mass. Transesophageal echocardiography (TEE) was evaluated. Transesophageal echocardiography (TEE) provides a thorough evaluation of the interatrial septum to distinguish benign lipomatous atrial septal hypertrophy from malignant intracardiac masses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: